UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

The role of osteoblasts in bone metastasis

Journal of bone oncology, 2016-09, Vol.5 (3), p.124-127

Ottewell, Penelope D

2016

Link zum Volltext

Verfügbarkeit prüfen

Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer

Current cancer drug targets, 2015-08, Vol.15 (6), p.469

2015

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer

JNCI : Journal of the National Cancer Institute, 2008-08, Vol.100 (16), p.1167-1178

2008

Link zum Volltext

Verfügbarkeit prüfen

Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone

Endocrine-related cancer, 2014-10, Vol.21 (5), p.769-781

2014

Link zum Volltext

Verfügbarkeit prüfen

The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo

Journal of bone oncology, 2019-08, Vol.17, p.100244-100244, Article 100244

2019

Link zum Volltext

Verfügbarkeit prüfen

Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer

International journal of molecular sciences, 2018-09, Vol.19 (10), p.2920

2018

Link zum Volltext

Verfügbarkeit prüfen

IL-1β in breast cancer bone metastasis

Expert reviews in molecular medicine, 2022-03, Vol.24, p.e11-e11, Article e11

2022

Link zum Volltext

Verfügbarkeit prüfen

Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo

Breast cancer research : BCR, 2012-05, Vol.14 (3), p.R86-R86, Article 3000

2012

Link zum Volltext

Verfügbarkeit prüfen

Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

International journal of cancer, 2010-01, Vol.126 (2), p.522-532

2010

Link zum Volltext

Verfügbarkeit prüfen

Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women

Frontiers in endocrinology (Lausanne), 2021-10, Vol.12, p.749428-749428

2021

Link zum Volltext

Verfügbarkeit prüfen

Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo

Clinical cancer research, 2008-07, Vol.14 (14), p.4658-4666

2008

Link zum Volltext

Verfügbarkeit prüfen

IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer

NPJ breast cancer, 2021-07, Vol.7 (1), p.95-95, Article 95

2021

Link zum Volltext

Verfügbarkeit prüfen

Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone

Molecular cancer therapeutics, 2009-10, Vol.8 (10), p.2821-2832

2009

Link zum Volltext

Verfügbarkeit prüfen

Combined therapies of bone disease with bisphosphonates

Current pharmaceutical design, 2010-01, Vol.16 (27), p.2988

2010

Link zum Volltext

Verfügbarkeit prüfen

Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine

The Journal of pathology, 2001-10, Vol.195 (3), p.285-292

2001

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention

Clinical & experimental metastasis, 2018-12, Vol.35 (8), p.831-846

2018

Link zum Volltext

Verfügbarkeit prüfen

From genetic abnormality to metastases : murine models of breast cancer and their use in the development of anticancer therapies

Breast cancer research and treatment, 2006-03, Vol.96 (2), p.101-113

2006

Link zum Volltext

Verfügbarkeit prüfen

The kinetochore protein Cenp‐F is a potential novel target for zoledronic acid in breast cancer cells

Journal of cellular and molecular medicine, 2011-03, Vol.15 (3), p.501-513

2011

Link zum Volltext

Verfügbarkeit prüfen

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo

Clinical cancer research, 2014-06, Vol.20 (11), p.2922-2932

2014

Link zum Volltext

Verfügbarkeit prüfen

CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment

JNCI : Journal of the National Cancer Institute, 2016-04, Vol.108 (4), p.1

2016

Link zum Volltext

Verfügbarkeit prüfen

The IL‐1/IL‐1R axis induces greater fibroblast‐derived chemokine release in human papillomavirus‐negative compared to positive oropharyngeal cancer

International journal of cancer, 2019-01, Vol.144 (2), p.334-344

2019

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Cells Preferentially Home to Osteoblast‐rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models

Journal of bone and mineral research, 2014-12, Vol.29 (12), p.2688-2696

2014

Link zum Volltext

Verfügbarkeit prüfen

Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis

Cancer letters, 2020-09, Vol.488, p.27-39

2020

Link zum Volltext

Verfügbarkeit prüfen

OPG‐Fc inhibits ovariectomy‐induced growth of disseminated breast cancer cells in bone

International journal of cancer, 2015-08, Vol.137 (4), p.968-977

2015

Link zum Volltext

Verfügbarkeit prüfen

Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancer

The FASEB journal, 2015-08, Vol.29 (8), p.3141-3150

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancers

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The role of osteoblasts in bone metastasis

Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer

Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer

Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone

The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo

Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer

IL-1β in breast cancer bone metastasis

Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo

Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women

Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo

IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer

Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone

Combined therapies of bone disease with bisphosphonates

Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine

Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention

From genetic abnormality to metastases : murine models of breast cancer and their use in the development of anticancer therapies

The kinetochore protein Cenp‐F is a potential novel target for zoledronic acid in breast cancer cells

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo

CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment

The IL‐1/IL‐1R axis induces greater fibroblast‐derived chemokine release in human papillomavirus‐negative compared to positive oropharyngeal cancer

Prostate Cancer Cells Preferentially Home to Osteoblast‐rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models

Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis

OPG‐Fc inhibits ovariectomy‐induced growth of disseminated breast cancer cells in bone

Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancer

Aktive Filter

Suchergebnisse filtern